Long-term treatment with Dawnzera (donidalorsen) — approved in the U.S. earlier this year for people with hereditary angioedema…
Articles by Andrea Lobo
Many patients in Brazil lack access to first-line treatments such as Takhzyro (lanadelumab) to prevent swelling attacks in hereditary…
Patient enrollment has started at sites in the European Union for a global Phase 3 clinical trial evaluating the safety…
Deucrictibant, an experimental treatment for angioedema attacks, was well tolerated and effective in four patients with acquired angioedema…
Late-treated and untreated swelling attacks in people with hereditary angioedema (HAE) are associated with a lower health-related quality of…
The U.S. Food and Drug Administration (FDA) has approved donidalorsen — to be marketed Dawnzera — as a prophylactic…
A woman in her 30s who experienced recurrent, nonspecific gastrointestinal symptoms was diagnosed with angioedema of the small intestine…
Navenibart, an experimental treatment from Astria Therapeutics to prevent swelling episodes in people with hereditary angioedema (HAE),…
The oral medication Orladeyo (berotralstat) is now approved in Colombia as a preventive treatment to reduce the risk of…
The prevalence of certain conditions — namely, allergies, autoimmune diseases, and asthma — is higher among people with hereditary…